NAP (Davunetide) Provides Functional and Structural Neuroprotection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|10|1040-1044

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.10, 2011-04, pp. : 1040-1044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3413-3417

Bentham Science Publishers

Access to resources Recommend Favorite

Protection Against Tauopathy by the Drug Candidates NAP (Davunetide) and D-SAL: Biochemical, Cellular and Behavioral Aspects

By  

Current Pharmaceutical Design, Vol. 17, Iss. 25, 2011-08 ,pp. : 2603-2612

Bentham Science Publishers

Access to resources Recommend Favorite

Stimulation of -adrenoceptors activates astrocytes and provides neuroprotection

By Junker V.   Becker A.   Huhne R.   Zembatov M.   Ravati A.   Culmsee C.   Krieglstein J.  

European Journal of Pharmacology, Vol. 446, Iss. 1, 2002-06 ,pp. : 25-36

Elsevier

Access to resources Recommend Favorite

Treatment with lutein provides neuroprotection in mice subjected to transient cerebral ischemia

By  

Journal of Asian Natural Products Research, Vol. 16, Iss. 11, 2014-11 ,pp. : 1084-1093

Taylor & Francis Ltd

Access to resources Recommend Favorite

Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2072-2082

Bentham Science Publishers

Access to resources Recommend Favorite